Navigation Links
Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment
Date:5/27/2010

HOOD RIVER, Ore., May 27 /PRNewswire/ -- According to the Center for Disease Control (CDC), autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. To give autism spectrum disorder (ASD) sufferers a natural alternative to chelation therapy, Maxam Nutraceutics (www.maxamlabs.com) has introduced PCA-Rx.

While chelation is commonly administered intravenously using the drug agents dimercaptosuccine acid (DMSA) and dimercaptopropane sulfonate (DMPS), this heavy metal removal method has come increasingly under fire by parents concerned about side effects.

Tina Beeck, who switched from chelation to PCA-Rx for treating her 4-year-old autistic son, Miller, stated, "We have been extremely pleased with PCA-Rx. We have seen tremendous cognitive gains – slowly at first and then dramatically. Sometimes he seems downright neuro-typical."

The result of years of rigorous research and development, PCA-Rx represents a breakthrough in toxin removal technology called Clathration Therapy. PCA-Rx is an epigenetic cell fermentation formula comprised of helpful bacteria and other microbes that, when used, become a natural, living part of the body's immune system. Administered orally, one to eight sprays per day under the tongue, it envelops, neutralizes and removes the harmful toxins through stool, urine, skin and breath, without ever touching vital organs or tissue.

PCA-Rx helps to eliminate heavy metals, chemical toxins and harmful parasite microorganisms; reduce cardio and cerebral vascular plaque; lower elevated enzyme counts; and decrease environmental illness effects.

"PCA-Rx represents the next generation of chelation technology," explained Maxam Nutraceutics President James Cole. "We're thrilled to provide autism sufferers a natural toxin removal treatment that's easy-to-use, powerful and with no known side effects."

PCA Rx is also used for Alzheimer's, candida, cervical dystonia, chemical exposure, heart disease, hepatitis, herpes, Lyme disease, paralysis, Niemann-Pick disease and uterine fibroids. It is available through www.maxamlabs.com.

For more information, or interview scheduling with James Cole, contact Renee Cooper, ChristieCommunications(www.christiecomm.com) or (805)969-3744, rcooper@christiecomm.com.

*PCA Rx has not been evaluated by the FDA and not intended to diagnose, treat, or cure any disease.


'/>"/>
SOURCE Maxam
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bioenergy Introduces Corvalen M(R) as a Natural Treatment Option for Fibromyalgia Symptoms
2. Bersin & Associates Introduces New Talent Management Framework
3. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
4. Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
5. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
6. Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
7. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
8. MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients
9. Burton Medical Introduces the AIM-200(R) as a Versatile, Long-Lasting Light Source for Ambulatory Surgical Centers
10. Sikorsky Global Helicopters Introduces State-of-the-Art Emergency Medical Services Interior for S-76(R) Helicopter
11. Samplify Introduces New Compression Technology to Lower Costs for Mobile Operators Migrating to 4G
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):